Risks for obesity-associated diseases and conditions

DOI: https://doi.org/10.29296/25877305-2023-02-11
Issue: 
2
Year: 
2023

Associate Professor M. Lyasnikova, Candidate of Medical Sciences; Associate Professor I. Tsvetkova, Candidate of Medical Sciences; Professor N. Belyakova, MD; Associate Professor A. Rodionov, Candidate of Medical Sciences; Associate Professor A. Lareva, Candidate of Medical Sciences; M. Silkina
Tver State Medical University

Alimentary-constitutional obesity is a chronic heterogeneous multifactorial disorder, the relevance of which can hardly be overestimated. The severe forms of this disorder are accompanied by specific complications, a high cardiometabolic risk, and obesity-related comorbidities. Objective. To study obesity-associated diseases and conditions. Subjects and methods. The investigation involved 426 overweight and obese patients. They underwent an examination that included historical data collection; physical examination for estimation of the severity of obesity and the grade of hypertension; abdominal ultrasound for diagnosis of hepatic steatosis or non-alcoholic fatty liver disease (NAFLD), and laboratory testing for a study of the parameters of carbohydrate and fat metabolisms and liver function. Results. Patients with severe alimentary-constitutional obesity had a higher risk of comorbidity: the risk of hypertension was elevated by 3.5-fold, type 2 diabetes mellitus and impaired glucose tolerance by 5-fold, metabolic syndrome by 4-fold, and NAFLD by 5.5-fold. Conclusion. Severe alimentary-constitutional obesity is a risk factor for comorbidity. At the same time, the solution of losing weight is a complex task to physicians of various specialties and consists of measures in both public health and patient commitment to a healthy lifestyle.
Keywords: 
associated diseases
hypertension
type 2 diabetes mellitus
metabolic syndrome
non-alcoholic fatty liver disease

References: 
  1. Diagnostika, lecheniye, profilaktika ozhireniya i assotsiirovannykh s nim zabolevaniy [Tekst: elektronnyy]. Natsional'nyye klinicheskiye rekomendatsii. SPb, 2017 (in Russ.). URL: https://mirvracha.ru/article/klinicheskie_rekomendatsii_po_diagnostike_i_lecheniyu_ozhireniya
  2. Verbovoy A., Sharonova L., Pashentseva A. et al. Insulin resistance and diseases of the internal organs. Vrach. 2017; 9: 17–22 (in Russ.).
  3. Ivanova A.Yu., Dolgalev I.V. Impact of overweight and obesity on mortality (according to the results of a 27-year prospective study). Profilakticheskaya Meditsina. 2017; 20 (3): 34–9 (in Russ.). DOI: 10.17116/profmed201720334-39
  4. Kologrivova I.V., Vinnitskaya I.V., Koshelskaya O.A. et al. Visceral obesity and cardiometabolic risk: features of hormonal and immune regulation. Obesity and metabolism. 2017; 14 (3): 3–10 (in Russ.). DOI: 10.14341/omet201733-10
  5. Komshilova K.A., Troshina E.A. Obesity and nonalcoholic fatty liver disease: metabolic risks and their correction. Obesity and metabolism. 2015; 12 (2): 35–9 (in Russ.). DOI: 10.14341/omet2015234-38
  6. Komshilova K.A., Troshina E.A. Obesity and non-alcoholic fatty liver disease personalized approaches to metabolic risks correction. Meditsinskiy sovet = Medical Council. 2018; 6: 132–6 (in Russ.). DOI: 10.21518/2079-701X-2018-6-132-136
  7. Bachar G.N., Dicker D., Kornowski R. et al. Epicardial adipose tissue as a predictor of coronary artery disease in asymptomatic subjects. Am J Cardiol. 2012; 110 (4): 534–8. DOI: 10.1016/j.amjcard.2012.04.024
  8. Lee Y.J., Shim J.Y., Moon B.S. et al. The relationship between arterial stiffness and nonalcoholic fatty liver disease. Dig Dis Sci. 2012; 57 (1): 196–203. DOI: 10.1007/s10620-011-1819-3
  9. López-Suárez A., Machann J., Schick F. et al. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol. 2011; 23 (11): 1011–7. DOI: 10.1097/MEG.0b013e32834b8d52
  10. Makarov I.O., Borovkov E.I., Kazakov R.D. Prevalence of non-alcoholic fatty liver disease among obese pregnant women. Obstetrics, Gynecology and Reproduction. 2012; 6 (4): 18–21 (in Russ.).
  11. Mu W. et al. Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues. Front Pharmacol. 2019; 9: 1566. DOI: 10.3389/fphar.2018.01566
  12. Pacana T., Fuchs M. The cardiovascular link to nonalcoholic fatty liver disease. Clin Liver Dis. 2012; 16 (3): 599–613. DOI: 10.1016/j.cld.2012.05.008
  13. Krysanova V.S. Zhuravleva M.V., Serebrova S.Yu. Sotsial'naya i ekonomicheskaya znachimost' izbytochnoi massy tela i ozhireniya v Rossiiskoi Federatsii. Osnovnye podkhody k lecheniyu ozhireniya. RMJ. 2015; 23 (26): 1534–7 (in Russ.).
  14. Morbidnoye ozhireniye. Pod obshch. red. I.I. Dedova. M.: Meditsinskoye informatsionnoye agentstvo, 2014; 608 р. (in Russ.).
  15. Bloomgarden Z.T. American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome. Diabetes Care. 2003; 26 (3): 933–9. DOI: 10.2337/diacare.26.3.933
  16. Recommendations for the management of patients with metabolic syndrome. Clinical guidelines Ministry of Health of the Russian Federation. 2013; 42 p. (in Russ.). URL: http://www.gipertonik.ru/clinical_recommendations
  17. Arterial'naya gipertenziya u vzroslykh. Klinicheskiye rekomendatsii. 2020; 162 р. (in Russ.).
  18. Reznik E.V., Nikitin I.G. New АСС/AHA and ESC/ESH arterial hypertension guidelines. Cardiovascular Therapy and Prevention. 2018; 17 (5): 99–119 (in Russ.). DOI: 10.15829/1728-8800-2018-5-99-119
  19. Grundy S.M., Cleeman J.I., Daniels S.R. et al. Diagnosis and Management of the Metabolic Syndrome. Circulation. 2005; 112 (17): 2735–52. DOI: 10.1161/CIRCULATIONAHA.105.169404
  20. Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom. Pod red. I.I. Dedova, M.V. Shestakovoy, A.Yu. Mayorova. 10 vyp. M., 2021; 223 р. (in Russ.).
  21. Global Health Observatory Data Repository. Report WHO [Internet]. Geneva: World Health Organization, 2013. Available from: http://www.euro.who.int/en/health-topics/diseaseprevention/nutrition/country-work/russian-federation2/
  22. Tsygankova D.P., Krivoshapova K.E., Maksimov S.A. et al. Obesity and hypertension: the role of criteria. Systemic Hypertension. 2019; 16 (1): 32–6 (in Russ.). DOI: 10.26442/2075082X.2019.180168
  23. Amlaev K., Blinkova L., Dakhkilgova Kh. Obesity: a modern view on the problem. Vrach. 2020; 31 (3): 3–10. (in Russ.). DOI: 10.29296/25877305-2020-03-01
  24. Mulerova T.A., Filimonov S.N., Onishchenko E.G. et al. Clinical relevance of body mass index, waist circumference and waist-to-hip ratio by patients with arterial hypertension in republic of Altai. Fundamental Research. 2012; 4 (2): 335–9 (in Russ.).
  25. Osipenko M.F., Kazakova Ye.A., Bikbulatova Ye.A., et al. Ozhireniye i bolezni organov pishchevareniya. Eksperimental'naya i klinicheskaya gastroenterologiya. 2013; 10: 49–50. (in Russ.).
  26. Bueverov A.O., Bogomolov P.O. Nonalcoholic fatty liver disease without obesity: the problem to be solved. Ter Arkh. 2017; 89 (12): 226–32 (in Russ.). DOI: 10.17116/terarkh20178912226-232